协和医学杂志2024，Vol.15Issue(2)：312-319,8.DOI:10.12290/xhyxzz.2024-0043
《2023 AHA/ACC/ACCP/ASPC/NLA/PCNA慢性冠状动脉疾病患者管理指南》要点解读
Interpretation on the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease
摘要
Abstract
In July 2023,the American Heart Association(AHA),the American College of Cardiology(ACC),and four other professional societies jointly released the updated version of the AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Artery Disease.This guide-line emphasizes a patient-centered and team-based approach to the overall management of chronic coronary artery disease(CCD),highlights the impact of lifestyle improvements on the prognosis of CCD patients,and provides new insights into risk assessment for major adverse cardiovascular events(MACE)and recommenda-tions for novel medications.These updates hold significant guiding value for health care professionals in China to provide high-quality management for CCD patients.关键词
慢性冠状动脉疾病/诊断/治疗/管理/指南Key words
chronic coronary artery disease/diagnosis/treatment/management/guidelines分类
医药卫生引用本文复制引用
梁岩..《2023 AHA/ACC/ACCP/ASPC/NLA/PCNA慢性冠状动脉疾病患者管理指南》要点解读[J].协和医学杂志,2024,15(2):312-319,8.基金项目
National Key R&D Program of China(2023YFC2413001) 国家重点研发计划(2023YFC2413001) （2023YFC2413001）
